ECYT
Endocyte, Inc. Common Stock
ECYT
ECYT
Delisted
ECYT was delisted on the 20th of December, 2018.
96 hedge funds and large institutions have $49.4M invested in Endocyte, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 31 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
96
Holders Change
-1
Holders Change %
-1.03%
% of All Funds
2.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
28
Reduced
31
Closed
10
Calls
$260K
Puts
$44K
Net Calls
+$216K
Net Calls Change
+$234K
Top Buyers
Top Sellers
| 1 |
BBA
Baker Bros. Advisors
New York
|
$3.63M |
| 2 |
Millennium Management
New York
|
$1.93M |
| 3 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
$932K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
$11.2M |
| 5 |
Morgan Stanley
New York
|
$244K |
